Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Pathways' Picks

EU Eyes Transition, CDRH Builds a Home, Medicare Picks, and More

In this week’s Pathways Picks: EU MDR group meets in advance of May 26 submission deadline; guidance documents related to EU performance studies and clinical investigations; CDRH builds Home as a Health Care Hub, and issues a biocompatibility analysis dataset; items from the Medicare inpatient rule; and updates from Germany, Australia, and China.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Start-Ups

PatenSee Revamps Hemodialysis Monitoring

Proper monitoring during hemodialysis is crucial for catching complications early before they develop into more costly and health-threatening situations, yet most clinicians lack the time to implement it consistently. PatenSee’s contact-free solution aims to improve monitoring protocols without adding to the clinical workload.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More